Skip to Main Content

Paper Details

AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
Cancer Epidemiol Biomarkers Prev
28
2007
31I allele, AURKA, AURKA F31I, AURKA oncogene, BRCA1, BRCA1/2, BRCA2, BRCA2 mutation, BRCA2 mutations, F31I, aneuploidy, breast cancer, cancer, chromosome, sporadic, sporadic breast tumors, tumor, tumors
Author NameAffiliation
Fergus J CouchMayo Clinic College of Medicine
Fergus J CouchMayo Clinic College of Medicine
  • 1 - 2

Datasets

Release 1.2